Details for New Drug Application (NDA): 063211
✉ Email this page to a colleague
The generic ingredient in ERYTHROMYCIN is erythromycin stearate. There are one hundred and three drug master file entries for this compound. Additional details are available on the erythromycin stearate profile page.
Summary for 063211
Tradename: | ERYTHROMYCIN |
Applicant: | Padagis Us |
Ingredient: | erythromycin |
Patents: | 0 |
Pharmacology for NDA: 063211
Physiological Effect | Decreased Sebaceous Gland Activity |
Medical Subject Heading (MeSH) Categories for 063211
Suppliers and Packaging for NDA: 063211
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ERYTHROMYCIN | erythromycin | GEL;TOPICAL | 063211 | ANDA | Padagis Israel Pharmaceuticals Ltd | 45802-966 | 45802-966-94 | 1 TUBE in 1 CARTON (45802-966-94) / 30 g in 1 TUBE |
ERYTHROMYCIN | erythromycin | GEL;TOPICAL | 063211 | ANDA | Padagis Israel Pharmaceuticals Ltd | 45802-966 | 45802-966-96 | 1 TUBE in 1 CARTON (45802-966-96) / 60 g in 1 TUBE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | GEL;TOPICAL | Strength | 2% | ||||
Approval Date: | Jan 29, 1993 | TE: | AT | RLD: | No |
Complete Access Available with Subscription